BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	190,852	261,031	307,053	375,171	332,528	316,749
Market Cap Growth	-21.59%	-14.99%	-18.16%	12.82%	4.98%	10.58%
Enterprise Value	175,840	254,201	306,536	371,611	332,698	316,732
Last Close Price	980.00	1700.00	1375.00	2132.23	1845.00	1734.00
PE Ratio	19.99	29.35	108.34	135.87	-	18.64
PS Ratio	3.36	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.72	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	1.85	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	12.50	25.70	290.28	350.06	77.63	-
P/OCF Ratio	11.38	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.31	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	12.66	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	14.39	21.40	97.60	348.42	-	-
EV/FCF Ratio	11.52	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Invested Capital (ROIC)	10.50%	8.84%	3.50%	1.18%	-1.74%	-2.46%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	5.00%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	8.00%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.